EverydayHealthLogo
Dr. Ann Arvin, MD

Dr. Ann Arvin, MD

Stanford, CA

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Arvin, Pediatric Infectious Diseases Specialist in Stanford, CA?

    Dr. Ann Arvin, MD is a Pediatric Infectious Diseases Specialist, who primarily practices in Stanford, CA with 2 additional practice locations. She is board certified. Dr. Arvin completed her residency at Mount Zion M C Univ Ca, Pediatrics; Moffitt Hosp Univ Of Ca, Pediatrics. Dr. Arvin is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Arvin’s office at (650) 497-8775.

    What are Areas of Expertise for Dr. Arvin?

    Dr. Ann Arvin, MD is a highly-rated, board-certified Pediatric Infectious Diseases Specialist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Arvin empowers patients to confidently navigate their health journey, specializing in Infectious Disease, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Arvin is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Arvin go to medical school and complete their residency?

    • Residency: Mount Zion M C Univ Ca, Pediatrics; Moffitt Hosp Univ Of Ca, Pediatrics | Moffitt Hospital University Of Ca

    • Medical School: University of Pa Sch of Med, Philadelphia Pa | Perelman School of Medicine University of Pennsylvania

    Is Dr. Arvin board certified as a Pediatric Infectious Diseases Specialist?

    Yes, Dr. Ann Arvin, MD is board certified by the American Board of Pediatrics

    What languages does Dr. Arvin speak?

    Dr. Arvin and their clinical team can communicate with patients in the following languages:

    • English

    • Spanish

    Which conditions does Dr. Arvin treat as a Pediatric Infectious Diseases Specialist?

    Which procedures does Dr. Arvin perform as a Pediatric Infectious Diseases Specialist?

    Does Dr. Arvin accept my insurance?

    Please contact Dr. Arvin's office to confirm accepted insurance plans.

    Where is Dr. Arvin's office located?

    Dr. Ann Arvin's Primary Practice

    300 Pasteur Dr # G312

    Stanford, CA 94305

    (650) 497-8775

    Get Directions

    Dr. Ann Arvin's Practice 2

    300 Pasteur Dr Dept Of

    Palo Alto, CA 94304

    Get Directions

    Dr. Ann Arvin's Practice 3

    730 Welch Rd Fl 2

    Palo Alto, CA 94304

    (650) 721-5805

    Get Directions

    Recognitions

    Publications

    Herpes Simplex Virus 1 Tropism for Human Sensory Ganglion Neurons

    JOURL OF VIROLOGY, 2013

    An immunoreceptor tyrosine-based inhibition motif in varicella

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2013

    3D Reconstruction of VZV Infected Cell Nuclei

    PLOS PATHOGENS, 2012

    Sigl transducer and activator of transcription 3

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2012

    Structure-function alysis of varicella

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2011

    Disruption of PML Nuclear Bodies Is Mediated by ORF61 SUMO-Interacting Motifs

    PLOS PATHOGENS, 2011

    Entrapment of Viral Capsids in Nuclear PML Cages Is an Intrinsic Antiviral Host Defense against

    PLOS PATHOGENS, 2011

    Varicella-Zoster Virus Immediate-Early Protein 62 Blocks Interferon Regulatory Factor 3

    JOURL OF VIROLOGY, 2010

    Functions of the unique N-termil region of glycoprotein E in the pathogenesis of varicella

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2010

    Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors.

    Virology, 2013

    ORF11 Protein Interacts with the ORF9 Essential Tegument Protein in Varicella

    JOURL OF VIROLOGY, 2013

    Identification of a Hydrophobic Domain in Varicella-Zoster Virus ORF61 Necessary for ORF61 Self

    JOURL OF VIROLOGY, 2013

    Inte Immune Dysfunction is Associated with Enhanced Dise

    JOURL OF INFECTIOUS DISEASES, 2013

    Investigation of varicella-zoster virus neurotropism

    JOURL OF NEUROVIROLOGY, 2011

    Varicella-Zoster Virus Infection Triggers Formation of an Interleukin-1 beta

    JOURL OF BIOLOGICAL CHEMISTRY, 2011

    Mutagenesis of Varicella-Zoster Virus Glycoprotein I

    JOURL OF VIROLOGY, 2011

    Identification and functiol characterization of the Varicella zoster virus ORF11 gene product

    VIROLOGY, 2011

    Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical

    JOURL OF INFECTIOUS DISEASES, 2011

    Varicella-Zoster Virus Glycoprotein E Is a Critical Determint of Virulence in the SCID Mouse

    JOURL OF VIROLOGY, 2011

    Impact of Varicella-Zoster Virus on Dendritic Cell Subsets in Human Skin during tural Infection

    JOURL OF VIROLOGY, 2010

    Expression of Varicella-Zoster Virus Immediate

    JOURL OF VIROLOGY, 2010

    Varicella-Zoster Virus Neurotropism in SCID Mouse-Human Dorsal Root Ganglia Xenografts

    VARICELLA-ZOSTER VIRUS, 2010

    Anti-Glycoprotein H Antibody Impairs the Pathogenicity of Varicella

    JOURL OF VIROLOGY, 2010

    Varicella-Zoster Virus T Cell Tropism and the Pathogenesis of Skin Infection

    VARICELLA-ZOSTER VIRUS, 2010

    Alysis of the Functions of Glycoproteins E and I and Their Promoters During VZV Replication In

    VARICELLA-ZOSTER VIRUS, 2010

    Age-Related Increase in the Frequency of CD4

    JOURL OF INFECTIOUS DISEASES, 2009

    Mutagenesis of Varicella-Zoster Virus Glycoprotein B

    JOURL OF VIROLOGY, 2009

    Regulation of the ORF61 Promoter and ORF61 Functions in Varicella

    JOURL OF VIROLOGY, 2009

    Varicella in the fetus and newborn

    SEMIRS IN FETAL & NEOTAL MEDICINE, 2009

    The Replication Cycle of Varicella-Zoster Virus

    JOURL OF VIROLOGY, 2009

    One Step Closer to a CMV Vaccine

    NEW ENGLAND JOURL OF MEDICINE, 2009

    Deletion of the first cysteine-rich region of the varicella

    Jourl of virology, 2009

    Development of recombint varicella

    JOURL OF VIROLOGICAL METHODS, 2008

    Functions of Varicella-Zoster Virus ORF23 Capsid Protein in Viral Replication

    JOURL OF VIROLOGY, 2008

    Influence of Prior Influenza Vaccition on Antibody and B-Cell Responses

    PLOS ONE, 2008

    Baseline Levels of Influenza-Specific CD4 Memory T

    PLOS ONE, 2008

    Immune responses to mumps vaccine in adults who were vaccited in childhood

    JOURL OF INFECTIOUS DISEASES, 2008

    Effects of interleukin-12

    VIRAL IMMUNOLOGY, 2008

    Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication

    JOURL OF VIROLOGY, 2008

    Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia

    JOURL OF VIROLOGY, 2008

    Primary vaccine failure after 1 dose of varicella vaccine in healthy children

    JOURL OF INFECTIOUS DISEASES, 2008

    Phenotypic changes in influenza-specific CD8

    JOURL OF INFECTIOUS DISEASES, 2008

    Varicella vaccine in the United States: A decade of prevention and the way forward

    JOURL OF INFECTIOUS DISEASES, 2008

    Humoral and cellular immunity to varicella-zoster virus: An overview

    JOURL OF INFECTIOUS DISEASES, 2008

    Deletion of the First Cysteine-Rich Region of the Varicella

    JOURL OF VIROLOGY, 2008

    A self-excisable infectious bacterial artificial chromosome clone of varicella

    JOURL OF VIROLOGY, 2007

    Age-dependent differences in IgG isotype

    JOURL OF INFECTIOUS DISEASES, 2007

    Cellular and viral factors regulate

    JOURL OF VIROLOGY, 2007

    Genetic alysis of varicella

    JOURL OF VIROLOGY, 2007

    Aberrant infection and persistence of varicella

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2007

    The ubiquitous cellular transcriptiol factor USF targets the varicella

    JOURL OF VIROLOGY, 2007

    Humoral and cellular immune responses in children given annual immunization with trivalent

    PEDIATRIC INFECTIOUS DISEASE JOURL, 2007

    Effect of materl herpes simplex virus (HSV) serostatus and HSV type on risk of neotal herpes

    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDIVICA, 2007

    Comparison of the influenza virus-specific effector

    JOURL OF VIROLOGY, 2007

    Cellular immune responses in children

    JOURL OF VIROLOGY, 2006

    ORF66 protein kise function is required for T-cell tropism of varicella-zoster virus in vivo

    JOURL OF VIROLOGY, 2006

    Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.

    Herpes : the jourl of the IHMF, 2006

    Essential functions of the unique N-termil region of the varicella

    JOURL OF VIROLOGY, 2006

    Variability and gender differences in memory T cell immunity to varicella

    VACCINE, 2006

    Materl herpes simplex virus antibody avidity and risk of neotal herpes

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 2006

    Inhibition of the NF-kappa B pathway by varicella-zoster virus in vitro

    JOURL OF VIROLOGY, 2006

    Control of varicella - Why is a two-dose schedule necessary?

    PEDIATRIC INFECTIOUS DISEASE JOURL, 2006

    A phase 1 study of 4 live, recombint human cytomegalovirus Towne/Toledo chimeric vaccines

    JOURL OF INFECTIOUS DISEASES, 2006

    Varicella-zoster virus open reading frame 10 is a virulence determint in skin cells but not in T

    JOURL OF VIROLOGY, 2006

    Mutatiol alysis of the Varicella-Zoster virus ORF62/63 Intergenic region

    JOURL OF VIROLOGY, 2006

    Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month

    VACCINE, 2006

    New viral vaccines

    VIROLOGY, 2006

    Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons

    JOURL OF VIROLOGY, 2006

    Reducing the global burden of congenital rubella syndrome

    JOURL OF INFECTIOUS DISEASES, 2005

    Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of

    ANTIVIRAL RESEARCH, 2005

    Strengthening the tion's influenza vaccition system - A tiol vaccine advisory committee assessment

    AMERICAN JOURL OF PREVENTIVE MEDICINE, 2005

    T-Cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection

    JOURL OF VIROLOGY, 2005

    Cell-type-dependent activation of the cellular EF-1 alpha promoter by the varicella-zoster virus

    VIROLOGY, 2005

    Aging, immunity, and the varicella-zoster virus

    NEW ENGLAND JOURL OF MEDICINE, 2005

    Varicella-zoster virus infection of human dorsal root ganglia in vivo

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2005

    Role of the varicella

    JOURL OF VIROLOGY, 2005

    Varicella-Zoster virus pathogenesis and immunobiology

    JOURL OF VIROLOGY, 2005

    Alysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka

    VIROLOGY, 2005

    Chickenpox party or varicella vaccine?

    HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN II, 2005

    Differential requirement for cell fusion

    JOURL OF VIROLOGY, 2004

    T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus

    JOURL OF CLINICAL INVESTIGATION, 2004

    Functions of the C-termil domain of varicella

    JOURL OF VIROLOGY, 2004

    Varicella-zoster virus transfer to skin by T cells

    JOURL OF EXPERIMENTAL MEDICINE, 2004

    Varicella-zoster virus infection of human neural cells in vivo

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2004

    Vaccine development to prevent cytomegalovirus disease

    CLINICAL INFECTIOUS DISEASES, 2004

    Humoral and cell-mediated immune responses to an early 2

    JOURL OF INFECTIOUS DISEASES, 2004

    T cell immunity to measles viral proteins in infants and adults after measles immunization

    VIRAL IMMUNOLOGY, 2004

    Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood

    JOURL OF INFECTIOUS DISEASES, 2004

    Persistent and selective deficiency of CD4

    JOURL OF IMMUNOLOGY, 2004

    The immediate-early 63 protein of varicella-zoster virus

    JOURL OF VIROLOGY, 2004

    Induction of cellular

    JOURL OF INFECTIOUS DISEASES, 2004

    Strengthening the supply of routinely recommended vaccines in the United States

    JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2003

    Requirement of Varicella-zoster virus immediate-early 4 protein for viral replication

    JOURL OF VIROLOGY, 2003

    Measles and mumps vaccition as a model to investigate the developing immune system

    VACCINE, 2003

    Identification of CD8+ T cell epitopes in the immediate early 62 protein

    JOURL OF INFECTIOUS DISEASES, 2003

    Construction of varicella-zoster virus recombints from parent Oka cosmids

    JOURL OF VIROLOGY, 2003

    Differentiation of varicella

    JOURL OF VIROLOGY, 2003

    Mutatiol alysis of open reading frames 62 and 71

    JOURL OF VIROLOGY, 2003

    Long term antiviral suppression after treatment for neotal herpes infection

    PEDIATRIC INFECTIOUS DISEASE JOURL, 2003

    Alysis of the frequencies and of the memory T cell phenotypes of human CD8

    JOURL OF INFECTIOUS DISEASES, 2003

    Microarray alysis of host cell gene transcription in response to varicella

    JOURL OF VIROLOGY, 2003

    Varicella-zoster virus infection facilitates VZV glycoprotein E trafficking to the membrane surface

    Jourl of medical virology, 2003

    Promoter sequences of varicella

    JOURL OF VIROLOGY, 2003

    The requirement of varicella zoster virus glycoprotein E

    VIROLOGY, 2002

    Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation

    JOURL OF VIROLOGY, 2002

    Latent cytomegalovirus down

    BLOOD, 2002

    The molecular epidemiology of varicella-zoster virus: Evidence for geographic segregation

    JOURL OF INFECTIOUS DISEASES, 2002

    Glycoprotein I of Varicella-zoster virus is required for viral replication in skin and T cells

    JOURL OF VIROLOGY, 2002

    Use of an ictivated varicella vaccine in recipients of hematopoietic-cell transplants

    NEW ENGLAND JOURL OF MEDICINE, 2002

    Debate: the argument against

    Herpes : the jourl of the IHMF, 2002

    Varlirix (GlaxoSmithKline).

    Current opinion in investigatiol drugs, 2002

    Memory cytotoxic T cell responses to viral tegument

    VIRAL IMMUNOLOGY, 2002

    Antiviral therapy for varicella and herpes zoster.

    Semirs in pediatric infectious diseases, 2002

    Quanitation of CD4+responder T cell frequencies to measles in vaccited infants and adults

    Gans, H. A., Alderson, A., Lew-Yasukawa, L., Rinki, M., DeHovitz, R., , 2001

    Immune responses to measles and mumps vaccition of infants at 6, 9, and 12 months

    Gans, H., Yasukawa, L., Rinki, M., DeHovitz, R., Forghani, B., Beeler,, 2001

    Mutatiol alysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69

    JOURL OF VIROLOGY, 2001

    Varicella-zoster virus: molecular virology and virus-host interactions

    CURRENT OPINION IN MICROBIOLOGY, 2001

    Safety and efficacy of high

    PEDIATRICS, 2001

    tural history of neotal herpes simplex virus infections in the acyclovir era

    PEDIATRICS, 2001

    Varicella vaccine: Genesis, efficacy, and attenuation

    VIROLOGY, 2001

    Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi

    JOURL OF VIROLOGY, 2001

    Varicella vaccine - The first six years.

    NEW ENGLAND JOURL OF MEDICINE, 2001

    Immune evasion as a pathogenic mechanism of varicella zoster virus

    SEMIRS IN IMMUNOLOGY, 2001

    Immune evasion mechanisms of varicella-zoster virus

    Abendroth, A., Arvin, A., 2001

    Granulysin blocks replication of varicella-zoster virus an

    What is Dr. Arvin's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Arvin's National Provider Identifier (NPI) number is 1982748463.

    What common questions do patients ask about Dr. Arvin?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Arvin

    What is Dr. Ann Arvin's specialty?

    Dr. Arvin is a Pediatric Infectious Diseases Specialist near Stanford, CA. A pediatrician trained in the diagnosis, treatment, and prevention of infectious diseases in children. This specialist utilizes their expertise to improve outcomes for pediatric infections, particularly those with complicated courses, underlying conditions that increase the risk of unusual or severe infections, ambiguous diagnoses, rare diseases, and complex or investigational treatments. Contact Dr. Arvin to book an appointment today.

    Is this Dr. Ann Arvin affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Arvin is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Pediatric Infectious Diseases Specialist?

    Explore Pediatric Infectious Diseases Specialist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Ann Arvin accepting new patients in Stanford, CA?

    Yes, Dr. Ann Arvin is accepting new patients at this time.

    Does Dr. Ann Arvin offer online booking?

    Please contact Dr. Arvin's office at (650) 497-8775 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Ann Arvin?

    Please contact Dr. Arvin's office at (650) 497-8775 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Ann Arvin have?

    Dr. Ann Arvin is certified by the American Board of Pediatrics.

    Other Pediatric Infectious Diseases Specialist Near Stanford, CA

    DN

    Pediatric Infectious Diseases Specialist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    SN

    Pediatric Infectious Diseases Specialist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    See All Specialists

    Doctors by Category

    Specialists